GORDON SCHUTZE to Antiretroviral Therapy, Highly Active
This is a "connection" page, showing publications GORDON SCHUTZE has written about Antiretroviral Therapy, Highly Active.
Connection Strength
0.369
-
Clinical Factors Associated with Long-Term Complete Remission versus Poor Response to Chemotherapy in HIV-Infected Children and Adolescents with Kaposi Sarcoma Receiving Bleomycin and Vincristine: A Retrospective Observational Study. PLoS One. 2016; 11(4):e0153335.
Score: 0.111
-
Clinical characteristics and outcomes of HIV-infected children diagnosed with Kaposi sarcoma in Malawi and Botswana. Pediatr Blood Cancer. 2013 Aug; 60(8):1274-80.
Score: 0.089
-
Experiencing antiretroviral adherence: helping healthcare staff better understand adherence to paediatric antiretrovirals. J Int AIDS Soc. 2010 Dec 06; 13:48.
Score: 0.076
-
Early clinical outcomes in children enrolled in human immunodeficiency virus infection care and treatment in lesotho. Pediatr Infect Dis J. 2010 Apr; 29(4):340-5.
Score: 0.073
-
Routine inpatient human immunodeficiency virus testing system increases access to pediatric human immunodeficiency virus care in sub-Saharan Africa. Pediatr Infect Dis J. 2011 May; 30(5):e75-81.
Score: 0.020